Pages that link to "Q44145511"
Jump to navigation
Jump to search
The following pages link to Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients (Q44145511):
Displaying 23 items.
- Breast pseudotumoral radionecrosis as a late radiation-induced injury: a case report (Q21202104) (← links)
- Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review (Q26775657) (← links)
- Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology (Q34560071) (← links)
- Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma (Q35606962) (← links)
- Antifibrotic effect of tamoxifen in a model of progressive renal disease (Q35720759) (← links)
- Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy (Q35743986) (← links)
- Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients (Q36695667) (← links)
- A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy (Q36874428) (← links)
- Breast radiation therapy guideline implementation in low- and middle-income countries (Q37287548) (← links)
- Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale? (Q37359033) (← links)
- Effects of hormonotherapy administered after concurrent radiotherapy and Trastuzumab on pulmonary fibrosis (Q37413375) (← links)
- Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group compa (Q37562603) (← links)
- Analysis of predictive factors for lung injury after forward-planned intensity-modulated radiotherapy in whole breast irradiation. (Q37705404) (← links)
- Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer (Q38792791) (← links)
- Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial (Q42648268) (← links)
- Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment (Q48531111) (← links)
- Concurrent versus sequential radiotherapy and tamoxifen in breast cancer – The CONSET trial is launched (Q48792181) (← links)
- Histopathologic Analysis of Tamoxifen on Epidural Fibrosis. (Q50079355) (← links)
- Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study (Q51313742) (← links)
- Estrogen Receptor Signaling in Radiotherapy: From Molecular Mechanisms to Clinical Studies. (Q52677343) (← links)
- Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target. (Q55339193) (← links)
- Changes in Pulmonary Function Up to 10 Years After Locoregional Breast Irradiation (Q83599400) (← links)
- Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report (Q98945880) (← links)